I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 25% ± 11% | |
| astrocyte | 11 studies | 33% ± 15% | |
| oligodendrocyte | 11 studies | 35% ± 11% | |
| microglial cell | 10 studies | 26% ± 9% | |
| oligodendrocyte precursor cell | 10 studies | 31% ± 13% | |
| glutamatergic neuron | 9 studies | 39% ± 25% | |
| GABAergic neuron | 8 studies | 38% ± 20% | |
| macrophage | 8 studies | 25% ± 6% | |
| fibroblast | 7 studies | 26% ± 7% | |
| neuron | 6 studies | 32% ± 17% | |
| interneuron | 6 studies | 39% ± 24% | |
| epithelial cell | 6 studies | 26% ± 8% | |
| adipocyte | 5 studies | 23% ± 4% | |
| endothelial cell of lymphatic vessel | 5 studies | 28% ± 9% | |
| granule cell | 4 studies | 24% ± 5% | |
| cardiac muscle cell | 4 studies | 22% ± 2% | |
| lymphocyte | 4 studies | 26% ± 7% | |
| mast cell | 4 studies | 24% ± 3% | |
| monocyte | 4 studies | 17% ± 1% | |
| pericyte | 4 studies | 29% ± 17% | |
| smooth muscle cell | 4 studies | 18% ± 2% | |
| GABAergic interneuron | 3 studies | 22% ± 5% | |
| B cell | 3 studies | 21% ± 3% | |
| myeloid cell | 3 studies | 21% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 15% ± 0% | |
| natural killer cell | 3 studies | 27% ± 13% | |
| basal cell | 3 studies | 21% ± 7% | |
| alveolar macrophage | 3 studies | 22% ± 5% | |
| transit amplifying cell | 3 studies | 24% ± 10% |
